News

TechNVision Ventures Ltd share price fell 5% to Rs 5125.25 after the company`s net profit witnessed a sharp fall of 166.51% to Rs 2.82 crore, while revenue from operations improved marginally 9.64% to Rs 73.58 crore in Q2FY26 over Q1FY26. The market capitalization of Software Products industry group stocks on BSE stood at Rs 1.12 lakh crore, rallying 21.29%. It has slipped by 1.07% over last one week and spiked sharply by 23.64% in last one month while the market capitalization of TechNVision Ventures Ltd has softened by 3.53% and 6.47% in the same period respectively. Profit before tax (PBT) of TechNVision Ventures Ltd stood at Rs 3.37 crore in Q2 FY26, expanding by 548.08% year-on-year, and nosediving by 201.81% quarter-on-quarter. EBITDA came in at Rs 3 crore, jumping 284.21% YoY and crashing by 185.63% sequentially. Total expenses remained flat to Rs 70.67 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 52.38 crore, slipping by 2.66% YoY. For the TTM ended FY26, revenue from operations grew 18.18% to Rs 227.81 crore, while net profit tumbled by 99.19% to Rs 0.11 crore, compared to previous TTM. EBITDA jumped by 1587% to Rs 2.19 crore, and PBT plunged by 92.99% to Rs 1.0 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 16.36 crore in FY26, as against Rs 19.92 crore in FY25. TechNVision Ventures Ltd soared by 20.02% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 2.83% during the same period.

TechNVision Ventures will hold a meeting of the Board of Directors of the Company on 13 August 2026.

Net Loss of TechNVision Ventures reported to Rs 4.24 crore in the quarter ended March 2026 as against net loss of Rs 0.83 crore during the previous quarter ended March 2025. Sales rose 70.55% to Rs 67.11 crore in the quarter ended March 2026 as against Rs 39.35 crore during the previous quarter ended March 2025.For the full year,net profit rose 100.00% to Rs 0.22 crore in the year ended March 2026 as against Rs 0.11 crore during the previous year ended March 2025. Sales rose 18.23% to Rs 269.34 crore in the year ended March 2026 as against Rs 227.81 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales67.1139.35 71 269.34227.81 18 OPM %-4.071.65 -2.091.60 - PBDT-2.49-0.08 -3013 5.643.19 77 PBT-3.31-0.77 -330 2.401.00 140 NP-4.24-0.83 -411 0.220.11 100 Powered by Capital Market - Live News

TechNVision Ventures will hold a meeting of the Board of Directors of the Company on 27 May 2026.

Solix Technologies (an affiliate of TechNVision Ventures) announced the signing of a Memorandum of Understanding (MoU) with Symbiosis Center for Entrepreneurship & Innovation (SCE) in collaboration with Symbiosis Medical College for Women (SMCW,), to establish a Center of Excellence (CoE) in New Drug Development and Drug Repurposing. The MoU was formalized during TAL HealthFest 2026, reinforcing the commitment of both institutions to advance innovation at the intersection of Artificial Intelligence, biomedical research, and translational medicine.The Center of Excellence aims to integrate: Computational intelligence and Al-driven in-silico modeling Molecular validation frameworks In-vivo translational research The initial focus areas will include: Alzheimer`s disease PAMR (Priority Antimicrobial Resistant) pathogens This collaboration brings together Solix`s 25+ years of expertise in end-to-end data lifecycle management, governance, and Enterprise Al with SMCW`s clinical, translational, and biomedical research strengths. Powered by Capital Market - Live News